Mounjaro Kwikpen 7.5mg Pre Filled Pen Of 3ml Solution For Injection
By ELI LILLY AND COMPANY
Refrigerated
3ml Solution For Injection in Pre Filled Pen
₹22000.00
₹7333.33/ml
(Inclusive of all taxes)
Out of Stock
3 days return policyRead More
All the Products are packed and stored Safely
Description
Mounjaro solution for injection is a prescription medication containing tirzepatide. It is used for adults with type 2 diabetes to help manage blood sugar when combined with a healthy diet and exercise. Mounjaro solution for injection is also prescribed for weight management when used in combination with a reduced-calorie diet and increased physical activity. Your doctor will provide specific instructions on dosage and administration.
Common side effects of Mounjaro solution for injection may include nausea, diarrhoea, vomiting, constipation, abdominal pain, and indigestion. These symptoms are generally mild and tend to improve over time. However, if they become severe or last a long time, it's important to consult a doctor.
Mounjaro solution for injection is not recommended for those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to conceive should avoid this medication due to potential risks to the developing baby.
Before starting this treatment, please inform your doctor of all other medications you are taking to prevent interactions.
Product Summary
| Offer Price | ₹22000.00 |
| You Save | |
| Contains | Tirzepatide(7.5 Mg) |
| Uses | Type 2 diabetes mellitus and management of obesity |
| Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain. |
| Therapy | ANTI-DIABETIC |
Uses
Mounjaro solution for injection is prescribed for adults with type 2 diabetes to control blood sugar when combined with diet and exercise. It is also used for weight management in conjunction with a low-calorie diet and increased physical activity. ...
Contraindications
If you are allergic to tirzepatide or any other ingredients of Mounjaro solution for injection.
Side effects
- Abdominal pain
- Constipation
- Indigestion
- Nausea
- Diarrhea
- Vomiting
Precautions and Warnings
Pregnancy
Q:
Can I take Mounjaro solution for injection during pregnancy?
A:
Mounjaro solution for injection is not advised during pregnancy and in women of childbearing potential who are not using contraception. If a patient plans to become pregnant, tirzepatide should be discontinued at least one month prior to the intended pregnancy due to its long half-life. Mounjaro solution for injection must not be used during pregnancy.
Breast Feeding
Q:
Can I take Mounjaro solution for injection while breastfeeding?
A:
Consult your doctor before using Mounjaro solution for injection while breastfeeding, as there is limited safety information regarding the use of this injection during that breastfeeding.
Driving
Q:
Can I drive if I have taken Mounjaro solution for injection?
A:
Mounjaro solution for injection has no or negligible influence on the ability to drive or operate machinery. When tirzepatide is used with a sulphonylurea or insulin, take precautions against hypoglycaemia when driving or operating machinery.
Alcohol
Q:
Can I consume alcohol with Mounjaro solution for injection?
A:
No known interactions with alcohol.
Other General Warnings
Talk to your doctor if
- You have a history of pancreatitis.
- You experience severe abdominal pain, nausea, or vomiting, which could indicate pancreatitis.
- You have type 2 diabetes and are taking insulin or a sulfonylurea, as you may be at an increased risk of hypoglycemia.
- You experience frequent nausea, vomiting, or diarrhoea, which may lead to dehydration and kidney issues.
- You have kidney disease, have had a kidney transplant, or have liver disease.
- You are elderly, especially if you are over 85 years old, as there is limited data on safety in this age group.
- You have a disease of the gallbladder or experience symptoms such as abdominal pain, yellowing of the skin or eyes (jaundice), clay-coloured stools, and fever.
- You have severe gastrointestinal disease, including gastroparesis (delayed emptying of the stomach due to reduced movement), as this injection has not been studied in such patients.
- You have eye problems, such as diabetic retinopathy or diabetic macular oedema, as this injection should be used cautiously in these conditions.
- You are scheduled for a procedure requiring general anaesthesia or deep sedation, as there is an increased risk of pulmonary aspiration.
- You notice any unusual changes in your vision while using this injection.
Directions for Use
Take Mounjaro solution for injection as directed by your doctor. Rotate injection sites with each dose.
Storage and disposal
- Store Mounjaro solution for injection in a refrigerator at a temperature between 2°C to 8°C.
- Do not freeze Mounjaro, and do not use this medicine if it has been frozen.
- Store it in the original carton to protect it from light.
Quick Tips
- To help keep your blood sugar levels steady, take Mounjaro solution for injection on the same day each week. Setting a reminder can help you stay on track.
- Rotate your injection sites (such as the abdomen, thigh, or upper arm) weekly to prevent skin irritation, bruising, or lumps.
- Regularly check your blood sugar to monitor for signs of low blood sugar, especially if you are on other diabetes medications.
- Eat small, frequent, and balanced meals, and avoid greasy or heavy foods to minimise nausea. Make sure to stay hydrated by drinking plenty of water, especially if you experience nausea, vomiting, or diarrhoea....
- Be aware of serious side effects such as intense stomach pain, signs of pancreatitis (like pain radiating to the back with nausea or fever), or allergic reactions. Contact your doctor immediately if any of these occur....
- Mounjaro solution for injection may interfere with oral contraceptives. To prevent unintended pregnancy, use a backup birth control method (such as condoms) or switch to a non-oral contraceptive for four weeks after starting treatment and for four weeks after any dose increase....
- Inform your doctor or surgeon that you’re using this injection if you have surgery scheduled, as it may slow down how your stomach empties and increase the risk of complications during anaesthesia.
Dosage
Overdose
In the event of an overdose, reach out to the nearest hospital.
Missed a Dose
Administer a missed dose within 4 days; if over 4 days, skip it and continue on the regular schedule. Resume weekly dosing thereafter.
Mode of Action
How Does It Work?
Tirzepatide mimics two natural hormones, GLP-1 and GIP, to enhance blood sugar control and promote weight loss. It stimulates insulin release, decreases liver glucose production, slows stomach emptying, and influences brain appetite centers, resulting in reduced hunger and cravings. This dual hormonal action helps regulate blood glucose levels and facilitates weight reduction....
Interactions
Interactions with other medicines
- Taking oral medications with a narrow therapeutic index, such as warfarin or digoxin, may be affected by tirzepatide, as it can alter their absorption.
- Using medications that require a rapid onset of action might be problematic since tirzepatide may delay their effects.
- Relying on oral contraceptives may be risky, as tirzepatide could reduce their effectiveness. It is advisable to consider switching to a non-oral contraceptive method or to use additional protection for four weeks after starting tirzepatide or increasing its dose....
- Having obesity or being overweight while using oral contraceptives may be concerning since tirzepatide can influence their efficacy.
- Frequently taking paracetamol might be impacted by tirzepatide, as it may delay its absorption; however, no dose adjustment is typically necessary.
Content Details
WRITTEN BY
Ravindra Ghongade
B. Pharm
REVIEWED BY
Dr. Nikita Toshi
BDS (Bachelor of Dental Surgery), WHO FIDES member
References
View All
- Lilly.com | Eli Lilly and Company [Internet]. www.lilly.com. [Cited 7 August 2025]
- Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. [Cited 7 August 2025]
- MOUNJAROTM (tirzepatide) Injection, for subcutaneous use. Initial U.S. Approval: 2022 [Internet]. uspl.lilly.com. [Cited 7 august 2025]
Did you find this medicine information helpful?
Please rate your experience
Product Details
Brand
MOUNJARO
Country of Origin
Usa
Expiry Date
11/11/2025
Manufacturer Details
Other Products from this Brand
View All
- MOUNJARO 2.5MG VIAL OF 0.5ML SOLUTION FOR INJECTION
- MOUNJARO 5MG VIAL OF 0.5ML SOLUTION FOR INJECTION
- MOUNJARO KWIKPEN 5MG PRE FILLED PEN OF 3ML SOLUTION FOR INJECTION
- MOUNJARO KWIKPEN 12.5MG PRE FILLED PEN OF 3ML SOLUTION FOR INJECTION
- MOUNJARO KWIKPEN 2.5MG PRE FILLED PEN OF 3ML SOLUTION FOR INJECTION
- MOUNJARO KWIKPEN 10MG PRE FILLED PEN OF 3ML SOLUTION FOR INJECTION
- MOUNJARO KWIKPEN 15MG PRE FILLED PEN OF 3ML SOLUTION FOR INJECTION
Blog Articles
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
Please add item(s) to proceed
